News & Updates

Psychotic disorders a potentially modifiable risk factor for dementia
Psychotic disorders a potentially modifiable risk factor for dementia
25 Oct 2022

Individuals with nonaffective psychotic disorders appear to have a twofold higher risk of developing subsequent dementia compared with those who do not have such disorders, as reported in a recent study.

Psychotic disorders a potentially modifiable risk factor for dementia
25 Oct 2022
Hypertension shows weak to no link to cognition in late life
Hypertension shows weak to no link to cognition in late life
13 Oct 2022

There appears to only be a very weak to no significant correlation between hypertension and cognitive function in late life, reports a recent study.

Hypertension shows weak to no link to cognition in late life
13 Oct 2022
Early noninferior to delayed NOAC initiation after stroke in AF patients
Early noninferior to delayed NOAC initiation after stroke in AF patients
13 Oct 2022

Early initiation of nonvitamin K antagonist oral anticoagulants (NOACs) after acute ischaemic stroke in patients with atrial fibrillation (AF) appears to yield similar outcomes when compared with delayed initiation, as shown in the results of the TIMING* study.

Early noninferior to delayed NOAC initiation after stroke in AF patients
13 Oct 2022
Safinamide for Parkinson’s: Dyskinesia up short term, motor symptoms down long term
Safinamide for Parkinson’s: Dyskinesia up short term, motor symptoms down long term
12 Oct 2022 byNatalia Reoutova

A post-hoc analysis of a phase III trial of long-term safinamide for Parkinson’s disease (PD) finds a significant early increase in pre-existing dyskinesia as well as improved motor symptoms in patients with or without pre-existing dyskinesia at 1 year.

Safinamide for Parkinson’s: Dyskinesia up short term, motor symptoms down long term
12 Oct 2022